Health product recall

Aved products recall: No market authorization

Brand(s)

Aved

Last updated

2026-04-02

Summary

Product Various Ophthalmic Solutions from Aved Issue Health products - Unauthorized product What to do Consult your health care professional if you have any health concerns.

Distribution National

Affected products

| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
| --- | --- | --- | --- | --- | --- |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.01% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.01% | 11122025@5, 01052026@11 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.02% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.02% | 10162025@3, 12052025@5, 01272026@13 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.025% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.025% | 10162025@5, 12082025@12, 01272026@14, 02252026@5 |
| Labtician Ophthalmics, Inc. / Aved | Atropine Sulfate 0.05% Ophthalmic Solution, 5 mL | No market authorization | Solution | Atropine Sulfate 0.05% | 10022025@3, 11202025@8, 01152026@6, 02042026@14 |
| Labtician Ophthalmics, Inc. / Aved | Fluorescein Na 0.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 5 mL | No market authorization | Solution | Fluorescein Na 0.25% / Proparacaine HCl 0.5% | 11202025@5, 12082025@11, 12232025@2, 01212026@10 |
| Labtician Ophthalmics, Inc. / Aved | Insulin Regular (Human) 25 IU/mL Ophthalmic Solution, 10 mL | No market authorization | Solution | Insulin 25 IU/mL | 10232025@3, 11142025@4, 12112025@3, 01222026@8 |
| Labtician Ophthalmics, Inc. / Aved | Mitomycin 0.04% Ophthalmic Solution (PF), 0.75 mL | No market authorization | Solution | Mitomycin 0.04% | 01192026@8 |
| Labtician Ophthalmics, Inc. / Aved | Moxifloxacin HCl 150 mcg/0.1 mL Ophthalmic Injection Solution, 0.75 mL | No market authorization | Solution | Moxifloxacin HCl 150 mcg/0.1 mL | 01192026@8 |
| Labtician Ophthalmics, Inc. / Aved | Prednisolone Sodium Phosphate 1% / Moxifloxacin 0.5% / Bromfenac 0.075% | No market authorization | Solution | Prednisolone Sodium Phosphate 1%/Moxifloxacin 0.5%/Bromfenac 0.075% | 12162026@11 |

Issue

Products sold without market authorization (DIN) in Canada due to third-party branding.

What you should do

1. Verify if your product is affected.
2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
3. Contact the recalling firm if you have any questions about the recall.
4. Report any health product related side effects to Health Canada.
5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers, Health Care Establishments

Details

Original published date:

2026-04-02

Alert / recall type Health product recall Category Health products - Drugs Companies Aved
44 Richmond St. West, Unit 202,

Oshawa, Ontario, L1G 1C7

Published by Health Canada Audience General public Healthcare Industry Distribution National Recall class Type III Identification number RA-81839

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe

Report a health or safety concern